Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Eddie Hickman is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/15/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/01/2025 | PMN | Buy Now | ProMIS Neurosciences | $0.63 | 858.62% | Eddie Hickman45% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2025 | ZVRA | Buy Now | Zevra Therapeutics | $6.98 | 215.19% | Eddie Hickman45% | $20 → $22 | Maintains | Buy | Get Alert |
| 03/13/2025 | GHRS | Buy Now | GH Research | $9.09 | 252.04% | Eddie Hickman45% | → $32 | Initiates | → Buy | Get Alert |
| 03/13/2025 | CYBN | Buy Now | Cybin | $7.72 | 353.37% | Eddie Hickman45% | → $35 | Initiates | → Buy | Get Alert |
| 02/26/2025 | PMN | Buy Now | ProMIS Neurosciences | $0.63 | — | Eddie Hickman45% | — | Reiterates | Buy → Buy | Get Alert |
| 02/26/2025 | TARS | Buy Now | Tarsus Pharmaceuticals | $48.72 | 60.1% | Eddie Hickman45% | $75 → $78 | Maintains | Buy | Get Alert |
| 02/24/2025 | TARS | Buy Now | Tarsus Pharmaceuticals | $48.72 | — | Eddie Hickman45% | — | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | TARS | Buy Now | Tarsus Pharmaceuticals | $48.72 | — | Eddie Hickman45% | — | Reiterates | Buy → Buy | Get Alert |
| 01/17/2025 | OTLK | Buy Now | Outlook Therapeutics | $1.43 | 739.16% | Eddie Hickman45% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 01/25/2024 | OTLK | Buy Now | Outlook Therapeutics | $1.43 | 39.86% | Eddie Hickman45% | → $40 | Upgrade | Neutral → Buy | Get Alert |
| 09/11/2023 | TARS | Buy Now | Tarsus Pharmaceuticals | $48.72 | 0.57% | Eddie Hickman45% | $46 → $49 | Maintains | Buy | Get Alert |
| 08/14/2023 | TARS | Buy Now | Tarsus Pharmaceuticals | $48.72 | -5.58% | Eddie Hickman45% | → $46 | Reiterates | Buy → Buy | Get Alert |
| 06/16/2023 | TARS | Buy Now | Tarsus Pharmaceuticals | $48.72 | -13.79% | Eddie Hickman45% | $40 → $42 | Maintains | Buy | Get Alert |
| 05/18/2023 | TARS | Buy Now | Tarsus Pharmaceuticals | $48.72 | — | Eddie Hickman45% | — | Initiates | → Buy | Get Alert |
| 05/01/2023 | ISEE | Buy Now | IVERIC bio | — | — | Eddie Hickman45% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/03/2023 | OTLK | Buy Now | Outlook Therapeutics | $1.43 | 249.65% | Eddie Hickman45% | → $100 | Initiates | → Buy | Get Alert |
| 09/07/2022 | ISEE | Buy Now | IVERIC bio | — | — | Eddie Hickman45% | $30 → $35 | Maintains | Buy | Get Alert |
